Kawsar R. Talaat, MD, IVS Director of Clinical Research, is a physician who is board certified in Internal Medicine, Pediatrics and Infectious Diseases. She has extensive experience in the design and conduct of Phase 1 and 2 clinical vaccine trials for new vaccines, and in the conduct of challenge studies. She has served as the Principal Investigator for Phase 1 or 2 trials for a variety of vaccines, including influenza (pandemic and seasonal), malaria, Ebola, and bacteria that cause diarrhea including Enterotoxigenic E. coli (ETEC) and Shigella. In addition to her work on novel vaccines, Dr. Talaat is interested in the safety of existing vaccines. She is the Johns Hopkins Principal Investigator for the CDC Clinical Immunization Safety Assessment group; Dr. Talaat has served on several working groups looking at vaccine safety and has co-authored a WHO-sponsored systematic review of the safety of influenza vaccines in children. She is also a member of the WHO Strategic Advisory Group of Experts Influenza Working Group.
Dr. Talaat is an Assistant Professor in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health and has a joint appointment in the Johns Hopkins School of Medicine.
